Dr. Kevin L. Mortara
Claim this profileBellin Memorial Hospital
Studies Cancer
Studies Lung Cancer
10 reported clinical trials
35 drugs studied
Area of expertise
1Cancer
Stage IV
ER positive
PR positive
2Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Kevin L. Mortara is currently running
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Kevin L. Mortara
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Kevin L. Mortara has experience with
- Atezolizumab
- Biospecimen Collection
- Fluorouracil
- Paclitaxel
- Radiation Therapy
- Stereotactic Body Radiation Therapy
Breakdown of trials Kevin L. Mortara has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin L. Mortara specialize in?
Kevin L. Mortara focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are ER positive.
Is Kevin L. Mortara currently recruiting for clinical trials?
Yes, Kevin L. Mortara is currently recruiting for 6 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Kevin L. Mortara has studied deeply?
Yes, Kevin L. Mortara has studied treatments such as Atezolizumab, Biospecimen Collection, Fluorouracil.
What is the best way to schedule an appointment with Kevin L. Mortara?
Apply for one of the trials that Kevin L. Mortara is conducting.
What is the office address of Kevin L. Mortara?
The office of Kevin L. Mortara is located at: Bellin Memorial Hospital, Green Bay, Wisconsin 54301 United States. This is the address for their practice at the Bellin Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.